Enterprise Value
1.576B
Cash
78.5M
Avg Qtr Burn
-21.23M
Short % of Float
8.88%
Insider Ownership
2.22%
Institutional Own.
69.04%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NARCAN (naloxone HCl) Details Opioid overdose | Approved Update | |
Vaxchora (pediatric) Details Cholera | Approved Quarterly sales | |
ACAM2000 Details Smallpox | Approved Quarterly sales | |
NARCAN (naloxone HCl) Details Opioid overdose | Approved Quarterly sales | |
Approved Quarterly sales | ||
CYFENDUS™ (AV7909 ) Details Anthrax | Approved Quarterly sales | |
Stabilized isoamyl nitrite (SIAN) Details Cyanide poisoning | Phase 1 Update | |
CHIKV VLP Details Chikungunya, Viral infection | Failed Discontinued | |
COVID-HIG Details COVID-19 | Failed Discontinued | |
FLU-IGIV Details Influenza | Failed Discontinued |